Login with ORCID

association

Full identifier: http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#association

Assigned to 1 class:

Minted in Nanopublication

 RATL0ZYwMU comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RATL0ZYwMU... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal)
(xsd:dateTime)
.
This is the identifier for this whole nanopublication. http://purl.org/np/RATL0ZYwMU... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RATL0ZYwMU... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RATL0ZYwMU... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC...
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: * cardiomyopathy and/or heart failure, recent myocardial infarction or severe arrhythmias [see Warnings and Precautions (5.3 * Previous treatment with maximum cumulative dose of anthracyclines [see Warnings and Precautions (5)] . * Hypersensitivity to epirubicin hydrochloride, other anthracyclines, or anthracenediones [see Adverse Reactions (6.2)]. Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: baseline neutrophil count < 1500 cells/mm 3; (4)."
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:54:02.882Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)